Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Circulating tumor cells predict survival in metastatic disease, data confirm
June 9th, 2005
Longer-term data on patients with metastatic breast cancer have further validated the predictive importance of circulating tumor cells (CTCs) in blood. Findings presented at the annual meeting of the American Society of Clinical Oncology expand on data previously reported in The New England Journal of Medicine (2004;351(8):781-791), according to Veridex, LLC. Of the 177 patients in the study, 53% of women with five or more CTCs per 7.5 mL of blood prior to therapy were found not to survive a year after initial diagnosis, versus 19% whose blood indicated fewer than five CTCs at the same point. Patients in the study were either about to start...
Source: Women's Health Weekly (2005-06-09)
|
